Infinity Pharmaceuticals Profit Margin

The latest profit margin for INFI is -1577.7% as of June 2023. That compares with -2110.33% in the prior-year period — up 25.2% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Infinity Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, INFI's profit margin moved from -2110.33% to -1577.7% — a 25.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Infinity Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, INFI currently prints -1577.7% for profit margin, while the sector average sits near 15.29%. That is roughly 10416.5% below the sector mean. Large gaps often invite a closer look at Infinity Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Infinity Pharmaceuticals converts resources into returns. At -1577.7%, INFI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -2110.33% in the prior-year period — up 25.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting INFI's profit margin (-1577.7%), review year-over-year change from -2110.33%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.